| Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis SR Goldsmith, MB Abid, JJ Auletta, A Bashey, A Beitinjaneh, P Castillo, ... Blood, The Journal of the American Society of Hematology 137 (23), 3291-3305, 2021 | 114 | 2021 |
| Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation M Slade, S Goldsmith, R Romee, JF DiPersio, ER Dubberke, P Westervelt, ... Transplant Infectious Disease 19 (1), e12629, 2017 | 97 | 2017 |
| Co-evolution of tumor and immune cells during progression of multiple myeloma R Liu, Q Gao, SM Foltz, JS Fowles, L Yao, JT Wang, S Cao, H Sun, ... Nature communications 12 (1), 2559, 2021 | 96 | 2021 |
| Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide SR Goldsmith, M Slade, JF DiPersio, P Westervelt, SJ Lawrence, GL Uy, ... haematologica 101 (11), e465, 2016 | 62 | 2016 |
| Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib SR Goldsmith, SSU Rehman, CL Shirai, K Vij, JF DiPersio Blood Advances 3 (23), 4131-4135, 2019 | 39 | 2019 |
| Saif Ur Rehman S, Shirai CL, Vij K, DiPersio JF SR Goldsmith Resolution of secondary hemophagocytic lymphohistiocytosis after treatment …, 2019 | 29 | 2019 |
| Donor-lymphocyte infusion following haploidentical hematopoietic cell transplantation with peripheral blood stem cell grafts and PTCy SR Goldsmith, M Slade, JF DiPersio, P Westervelt, MA Schroeder, F Gao, ... Bone Marrow Transplantation 52 (12), 1623-1628, 2017 | 29 | 2017 |
| Post-transplantation cyclophosphamide is associated with an increase in non-cytomegalovirus herpesvirus infections in patients with acute leukemia and myelodysplastic syndrome A Singh, CE Dandoy, M Chen, S Kim, CM Mulroney, MA Kharfan-Dabaja, ... Transplantation and cellular therapy 28 (1), 48. e1-48. e10, 2022 | 25 | 2022 |
| Newly diagnosed myeloma in 2020 P Moreau, C Touzeau, R Vij, SR Goldsmith, AE Rosko American Society of Clinical Oncology Educational Book 40, e144-e158, 2020 | 22 | 2020 |
| Hematopoeitic cell transplantation and CAR T-cell therapy: complements or competitors? SR Goldsmith, A Ghobadi, JF DiPersio Frontiers in Oncology 10, 608916, 2020 | 20 | 2020 |
| Next generation sequencing-based validation of the revised international staging system for multiple myeloma: an analysis of the MMRF CoMMpass study SR Goldsmith, MA Fiala, J Dukeman, A Ghobadi, K Stockerl-Goldstein, ... Clinical Lymphoma Myeloma and Leukemia 19 (5), 285-289, 2019 | 20 | 2019 |
| DCEP and bendamustine/prednisone as salvage therapy for quad-and penta-refractory multiple myeloma SR Goldsmith, MA Fiala, B Wang, MA Schroeder, TM Wildes, A Ghobadi, ... Annals of Hematology 99, 1041-1048, 2020 | 18 | 2020 |
| Incidence and impact of community respiratory viral infections in post‐transplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis and … CM Mulroney, MB Abid, A Bashey, RF Chemaly, SO Ciurea, M Chen, ... British journal of haematology 194 (1), 145-157, 2021 | 17 | 2021 |
| Sarcoidosis manifesting as a pseudotumorous renal mass S Goldsmith, M Harris, K Scherer, S Al-Quran, E Vorhis Journal of Radiology Case Reports 7 (5), 23, 2013 | 15 | 2013 |
| Daratumumab for the treatment of multiple myeloma. SR Goldsmith, N Foley, MA Schroeder Drugs of Today (Barcelona, Spain: 1998) 57 (10), 591-605, 2021 | 13 | 2021 |
| Single-cell discovery and multiomic characterization of therapeutic targets in multiple myeloma L Yao, JT Wang, RG Jayasinghe, J O'Neal, CF Tsai, MP Rettig, Y Song, ... Cancer research 83 (8), 1214-1233, 2023 | 12 | 2023 |
| Glasdegib for the treatment of adult patients with newly diagnosed acute myeloid leukemia or high-grade myelodysplastic syndrome who are elderly or otherwise unfit for standard … SR Goldsmith, AR Lovell, MA Schroeder Drugs of Today (Barcelona, Spain: 1998) 55 (9), 545-562, 2019 | 11 | 2019 |
| EZH2 overexpression in multiple myeloma: prognostic value, correlation with clinical characteristics, and possible mechanisms SR Goldsmith, MA Fiala, J O’Neal, GP Souroullas, W Toama, R Vij, ... Clinical Lymphoma Myeloma and Leukemia 19 (11), 744-750, 2019 | 10 | 2019 |
| A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma Y Sawalha, S Goyal, JM Switchenko, JT Romancik, M Kamdar, ... Blood advances 7 (13), 2983-2993, 2023 | 9 | 2023 |
| Chimeric antigen receptor T cell therapy versus hematopoietic stem cell transplantation: an evolving perspective SR Goldsmith, A Ghobadi, JF Dipersio, B Hill, M Shadman, T Jain Transplantation and cellular therapy 28 (11), 727-736, 2022 | 9 | 2022 |
